View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 5, 2022

Bumrungrad International Hospital to deploy Lunit’s cancer screening products

Lunit has collaborated with FujiFilm Thailand and Microsoft to deliver INSIGHT CXR software and Lunit INSIGHT MMG.

Bumrungrad International Hospital in Thailand is set to deploy Lunit’s artificial intelligence (AI) cancer screening products.

Free Whitepaper
img

Disruptive start-ups to watch out for

2021 was a record-breaking year, with more businesses breaking into the billion-dollar club. Many start-ups have achieved or retained the unicorn status by the end of the year to reflect nearly a fivefold growth from that in 2020. This boom can be linked to a financing frenzy spurred by the quick adoption of technology and innovative solutions by start-ups gaining traction in response to the pandemic. However, the start-up ecosystem is now facing turbulent times for fundraising as investors seek long-term business strategies, valuations, and a route to profitability amid uncertain market circumstances. Nevertheless, 2022 has the potential to carry forward the momentum with multiple entities having a fair chance of being in the right place when aided by the right technologies. GlobalData leverages the power of alternative data to examine the health of start-ups across multiple dimensions including the quality of their innovations, market presence, and the funding they can attract. This helps our clients to analyze the disruptive potential of start-ups for early alliances, investments, and acquisition prospects to develop future-proof strategic roadmaps for a competitive advantage. Read our report and gather insights on the following topics:
  • Recent Unicorn trends
  • Unicorns in 2022
  • Future Unicorns
  • Start-ups to watch out for
Start-up ecosystem outlook by top geographies
by GlobalData
Enter your details here to receive your free Whitepaper.

Lunit has signed a contract with FujiFilm Thailand and Microsoft to deliver the products.

As part of the agreement, Lunit will supply CE-marked chest x-ray analysis AI software INSIGHT CXR, and Lunit INSIGHT MMG, an FDA-cleared AI solution to detect breast cancer in early stages, to the hospital.

The AI-based system will enable the hospital to detect chest abnormalities and breast cancer in their early stages and provide timely treatment.

While Lunit and FujiFilm Thailand will supply the AI solutions to the Bumrungrad hospital, cloud computing platform Microsoft Azure will improve the operation of the software.

Lunit and Microsoft have been collaborating to equip global diagnostic practices with medical AI solutions.

Lunit CEO Brandon Suh said: “We are delighted to introduce our AI solutions to Bumrungrad, which strives to ensure a healthier life for patients.

“We also expect the partnership with Microsoft, a leading cloud service provider, will expand the reach of Lunit INSIGHT CXR and Lunit INSIGHT MMG into further sites across the world so that our INSIGHT suite supports more hospitals detecting critical findings.”

Lunit AI solutions have already been deployed in the hospital for check-ups, intensive care units, emergency rooms, among other services.

The new Lunit INSIGHT CXR and Lunit INSIGHT MMG will help the hospital analyse over 100,000 medical images annually.

Furthermore, Lunit plans to support Bumrungrad to encourage medical innovation across Southeast Asia.

Bumrungrad International Hospital Research and Development director Dr Teeradache Viangteeravat said: “An additional benefit we anticipate for the AI system is its ability to speed up the learning curve for junior doctors with less experience in reading images.”

With 580 beds, Bumrungrad treats 1.1 million patients annually from over 190 countries.

Related Companies

Free Whitepaper
img

Disruptive start-ups to watch out for

2021 was a record-breaking year, with more businesses breaking into the billion-dollar club. Many start-ups have achieved or retained the unicorn status by the end of the year to reflect nearly a fivefold growth from that in 2020. This boom can be linked to a financing frenzy spurred by the quick adoption of technology and innovative solutions by start-ups gaining traction in response to the pandemic. However, the start-up ecosystem is now facing turbulent times for fundraising as investors seek long-term business strategies, valuations, and a route to profitability amid uncertain market circumstances. Nevertheless, 2022 has the potential to carry forward the momentum with multiple entities having a fair chance of being in the right place when aided by the right technologies. GlobalData leverages the power of alternative data to examine the health of start-ups across multiple dimensions including the quality of their innovations, market presence, and the funding they can attract. This helps our clients to analyze the disruptive potential of start-ups for early alliances, investments, and acquisition prospects to develop future-proof strategic roadmaps for a competitive advantage. Read our report and gather insights on the following topics:
  • Recent Unicorn trends
  • Unicorns in 2022
  • Future Unicorns
  • Start-ups to watch out for
Start-up ecosystem outlook by top geographies
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management